ClinicalTrials.Veeva

Menu

Role of Folinic Acid in Improving the Adaptive Skills and Language Impairment in Children With Autism Spectrum Disorder

N

Nishtar Medical University

Status and phase

Completed
Phase 2

Conditions

Autism Spectrum Disorder

Treatments

Drug: Folinic Acid

Study type

Interventional

Funder types

Other

Identifiers

NCT05013164
ICHMultan

Details and patient eligibility

About

No such study has been conducted in Pakistan so the primary objective of this study was to determine the role of folinic acid in improving the speech and adaptive skills while secondary objective was improvement of stereotype movements and hyperactivity in ASD among children aged 3 to 14 years.

Enrollment

44 patients

Sex

All

Ages

3 to 14 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Children of both genders aged 3 to 14 years with diagnosis of autism spectrum disorder established by DSM-5 Criteria, Childhood Autism Rating Scale (CARS) scoring and clinical examination along with documentation of Language Impairment

Exclusion criteria

  • All children having autism with seizure disorder, autism with serious medical illness within last 6 months or those with autism with well-defined genetic syndrome.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

44 participants in 2 patient groups

Folinic Acid + Behavioral Therapy
Experimental group
Description:
Children receiving folinic acid and behavioral therapy. Folinic Acid was given at the dose of 2mg/kg per day in two divide doses( maximum 50 mg per day) given for 12 weeks.
Treatment:
Drug: Folinic Acid
Behavioral Therapy
No Intervention group
Description:
Children received only behavioral therapy for 12 weeks.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems